Skip to content

Self-management in type 2 diabetes patients on insulin therapy triggered by app-messages

Self-management in type 2 diabetes patients on insulin therapy triggered by app-messages

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON23768
Enrollment
228
Registered
2015-11-18
Start date
2015-11-23
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 2 diabetes mellitus, eHealth, mHealth, self-management, behavioural change, insulin therapy

Interventions

Text-messages via a smartphone app aiming to trigger diabetes self-management of type 2 diabetes patients on insulin therapy. These app-triggers are evidence and psychological theory based, unidirecti

Sponsors

University Medical Center Utrecht
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Eligible participants are type 2 diabetes patients on insulin treatment since at least three months, with a baseline HbA1c >53 mmol/mol (>7%) with no upper limit, aged 40-70 years and treated for their diabetes in primary or secondary care. Logistic requirements are the possession of an e-mail address and a smartphone.

Exclusion criteria

Exclusion criteria: Exclusion criteria are a history of alcoholism, drug abuse, dementia or major psychiatric disorder that is likely to invalidate informed consent or limit the ability of the individual to comply with the protocol requirements.

Design outcomes

Primary

MeasureTime frame
The primary study endpoints are 1) the percentage of patients who achieve an HbA1c level <53 mmol/mol (<7%) without hypoglycaemia (plasma glucose <3.5 mmol/L (<63 mg/dL), and 2) the HbA1c level (continuous variable) after a follow-up of six months.

Secondary

MeasureTime frame
Secondary outcomes are body mass index, body weight, waist circumference, insulin dose, lipoprotein profile, blood pressure, number of hypoglycaemic events, glycaemic variability, self-management (SDSQ), food habits (FFQ), physical activity (IPAQ), health status (EQ-5D, SF36), diabetes-dependent quality of life (ADDQoL), patient¡¯s satisfaction (DTSQ) and satisfaction with the app; the cost-effectiveness of the intervention after six months; sustainability of the intervention (three months extra follow-up).

Contacts

Public ContactAnne Meike Boels

Universitair Medisch Centrum Utrecht, divisie Julius Centrum

a.m.boels-2@umcutrecht.nl-

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)